$Arcutis Biotherapeutics (ARQT.US)$ anyone know why this sto...
$Arcutis Biotherapeutics (ARQT.US)$ anyone know why this stock is being murdered?
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Chris Koumentakos : Cause an executive sold $600k and then a director sold another $80k.
Chris Koumentakos : They’re up 1500%. Stock will return to $12 if not $16 in August.
MommaCrazy OP Chris Koumentakos : I saw the sales. one was replaced with calls and another executed some at a $1 or so to replace some of the ones sold at $8 from what I remember. there is the generic patent infringement issue from Padagis, they filed NDA generic Roflumilast. 15% cream. they did something similar to Bausch, but they won... might have added to the drop.
Mod Tanyatorn : Its going $20-30 i believe if the FDA is approve. We will know by next Monday. Company has huge positive cash flow, reduce costing YoY.